Crosslink Therapeutics Inc. — Form D
Crosslink Therapeutics Inc. of BOSTON, MA, a company, filed a Form D exempt-offering notice with the SEC on 2025-05-15. The offering totals $8.0M, of which $4.3M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2025-05-15
- Form: D
- Accession: 0002067583-25-000002
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $8.0M
- Amount sold: $4.3M
- Remaining: $3.8M
- Investors: 6
- Date of first sale: 2025-04-17
- Revenue range: Decline to Disclose
- SEC file number: 021-546247
Issuer
- Name: Crosslink Therapeutics Inc.
- CIK: 0002067583
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: 349-351 NEWBURY STREET, BOSTON, MA, 02115
- Phone: 404-861-1253
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Rodolfo D Chaparro | Director | Boston, MA |
| Cameron D Gallagher | Director | Boston, MA |
| Ronald D Seidel, III | Director | Boston, MA |
| Lou D Tartaglia | Director | Boston, MA |
| Andrew D King | Executive Officer | Boston, MA |
| Ronald D Seidel, III | Executive Officer | Boston, MA |
More